HK1051650A1 - Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response. - Google Patents

Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response.

Info

Publication number
HK1051650A1
HK1051650A1 HK03103906A HK03103906A HK1051650A1 HK 1051650 A1 HK1051650 A1 HK 1051650A1 HK 03103906 A HK03103906 A HK 03103906A HK 03103906 A HK03103906 A HK 03103906A HK 1051650 A1 HK1051650 A1 HK 1051650A1
Authority
HK
Hong Kong
Prior art keywords
enhancement
immune response
carbohydrate formulation
prebiotic
adjuvant
Prior art date
Application number
HK03103906A
Other languages
English (en)
Inventor
Ferdinand Haschke
Anne-Lise Carrie
Zdenek Kratky
Harriet Link-Amster
Florence Rochat
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of HK1051650A1 publication Critical patent/HK1051650A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Grain Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK03103906A 2000-03-01 2003-06-02 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response. HK1051650A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200735 2000-03-01
PCT/EP2001/001627 WO2001064225A1 (en) 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Publications (1)

Publication Number Publication Date
HK1051650A1 true HK1051650A1 (en) 2003-08-15

Family

ID=8171132

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03103906A HK1051650A1 (en) 2000-03-01 2003-06-02 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response.

Country Status (22)

Country Link
US (2) US20030040492A1 (es)
EP (1) EP1261355B1 (es)
JP (1) JP4838477B2 (es)
KR (1) KR20020081375A (es)
CN (1) CN1243551C (es)
AR (1) AR027968A1 (es)
AT (1) ATE283697T1 (es)
AU (2) AU2001231746C1 (es)
BR (1) BR0108828A (es)
CA (1) CA2400969C (es)
DE (1) DE60107544T2 (es)
ES (1) ES2232591T3 (es)
HK (1) HK1051650A1 (es)
HU (1) HUP0204546A3 (es)
IL (1) IL151280A0 (es)
MX (1) MXPA02008447A (es)
NO (1) NO20024011D0 (es)
PL (1) PL365136A1 (es)
PT (1) PT1261355E (es)
UA (1) UA73763C2 (es)
WO (1) WO2001064225A1 (es)
ZA (1) ZA200207849B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en) 1999-07-23 2001-11-20 Mcdevitt Dennis System and method for attaching soft tissue to bone
KR20020043078A (ko) * 2000-12-01 2002-06-08 한인규 올리고당이 포함된 복합생균제
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
PT1638416E (pt) * 2003-06-23 2013-07-08 Nestec Sa Utilização de uma fórmula nutricional para função de barreira intestinal óptima
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
US20050118299A1 (en) * 2003-12-01 2005-06-02 The Iams Company Companion animal compositions comprising short chain oligofructose
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
US20100055083A1 (en) * 2006-10-18 2010-03-04 Ray Edward Kowalski Encapsulation of heat and moisture sensitive substances
DE102007008664B4 (de) * 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
US20110104335A1 (en) * 2007-08-24 2011-05-05 Luc Rumbaut Process and confectionery product produced thereby
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
ES2656776T3 (es) 2008-06-13 2018-02-28 N.V. Nutricia Composición nutricional para bebés nacidos por cesárea
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
WO2011008086A1 (en) 2009-07-15 2011-01-20 N.V. Nutricia Mixture of non-digestible oligosaccharides for stimulating the immune system
PL3342413T3 (pl) 2009-07-15 2022-03-28 N.V. Nutricia Fukozylolaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania biegunce wirusowej
CN104206946A (zh) 2009-11-12 2014-12-17 雀巢产品技术援助有限公司 用于促进肠微生物群平衡和健康的营养组合物
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
WO2013149017A1 (en) * 2012-03-28 2013-10-03 Kansas State University Research Foundation Vaccine adjuvant
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
CN103330935A (zh) * 2013-06-17 2013-10-02 中山大学 果糖作为疫苗佐剂的应用
WO2017021413A1 (en) * 2015-08-04 2017-02-09 Südzucker AG Prophylactic use of inulin against sinusitis
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
BR112020004264A2 (pt) 2017-09-08 2020-10-06 Evelo Biosciences, Inc. vesículas extracelulares bacterianas
AU2018330323A1 (en) * 2017-09-08 2020-03-19 Evelo Biosciences, Inc. Extracellular vesicles from Prevotella
JP7469037B2 (ja) * 2019-02-28 2024-04-16 森永乳業株式会社 発酵乳
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002679A1 (en) * 1985-10-31 1987-05-07 The Australian National University Immunotherapeutic treatment
US5422346A (en) * 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrierte Fructooligosaccharide
DE69520528T2 (de) * 1994-06-14 2001-09-27 Raffinerie Tirlemontoise Sa Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia Yomo Spa Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

Also Published As

Publication number Publication date
MXPA02008447A (es) 2002-12-13
NO20024011L (no) 2002-08-22
EP1261355A1 (en) 2002-12-04
CA2400969C (en) 2011-04-19
US20040191234A1 (en) 2004-09-30
CA2400969A1 (en) 2001-09-07
IL151280A0 (en) 2003-04-10
US20030040492A1 (en) 2003-02-27
HUP0204546A2 (en) 2003-05-28
DE60107544D1 (de) 2005-01-05
WO2001064225A1 (en) 2001-09-07
DE60107544T2 (de) 2005-12-15
AU2001231746B2 (en) 2004-12-23
ZA200207849B (en) 2003-12-30
AU3174601A (en) 2001-09-12
HUP0204546A3 (en) 2003-10-28
ATE283697T1 (de) 2004-12-15
AR027968A1 (es) 2003-04-16
AU2001231746C1 (en) 2005-10-06
CN1422158A (zh) 2003-06-04
BR0108828A (pt) 2002-12-10
CN1243551C (zh) 2006-03-01
ES2232591T3 (es) 2005-06-01
JP2003533438A (ja) 2003-11-11
PT1261355E (pt) 2005-02-28
KR20020081375A (ko) 2002-10-26
PL365136A1 (en) 2004-12-27
EP1261355B1 (en) 2004-12-01
JP4838477B2 (ja) 2011-12-14
US7101553B2 (en) 2006-09-05
UA73763C2 (en) 2005-09-15
NO20024011D0 (no) 2002-08-22

Similar Documents

Publication Publication Date Title
HK1051650A1 (en) Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response.
IL218666A0 (en) Enhancement of antibody-medicated immune responses
EP1467615A4 (en) PROCESS FOR THE ENGINEERING OF MAMMALIAN TYPE CARBOHYDRATE STRUCTURES
AUPR174800A0 (en) Semiconductor processing
EP1461074A4 (en) MEANS FOR REINFORCING THE IMMUNE RESPONSE
AU2001286653A1 (en) Manufacturing orthopedic parts using supercritical fluid processing
MXPA03001007A (es) Procedimientos para la preparacion de absorbentes de uv de benzotriazol.
AU2001286712A1 (en) Orthopedic mixtures prepared by supercritical fluid processing techniques
EP1352980A4 (en) SILICON RICH STAINLESS STEEL
MXPA03006587A (es) Quimiocinas como adyuvantes de respuesta inmune.
AU2002365924A8 (en) Herbal immune system stimulant
GB2364642B (en) Compositions for enhancing the immune response
IL139832A0 (en) Therapeutic compositions that produce an immune response by altering the antigen
HK1047406A1 (zh) Hiv免疫佐劑治療
GB2390811B (en) Therapeutic compositions that alter the immune response
WO2002017961A1 (fr) Preparation d'un vaccin renfermant un acide gras comme compose
MXPA03004071A (es) Formulaciones de combinacion de adyuvantes.
EP1313839A4 (en) IMMUNE POTENTIALIZING COMPOSITIONS
ZA200108619B (en) Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide.
AU6604701A (en) Method to induce the TH1 immune response
DK1261355T3 (da) Carbohydratformulering (præbiotisk adjuvans) til forstærkning af immunresponset
AU2002364161A8 (en) Enhancement of the immune response using cd36-binding domain
ZA200004975B (en) Adjuvant compositions.
GB0107885D0 (en) Steam processing
ZA9810275B (en) Therapeutic compositions that produce an immune response.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100214